Leveraging insights from The Cancer Genome Atlas (TCGA) database, our endeavor aims to illuminate the nuanced molecular implications and clinical relevance of KIR3DL2 in the context of HCC recurrence. This evidence concerns the gene KIR3DL2 and hepatocellular carcinoma.